Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zoufaly, Alexander ^a   Cozzi Lepri, Alessandro ^b   Reekie, Joanne ^b   Kirk, Ole ^c   Lundgren, Jens ^c   Reiss, Peter ^d,bj   Jevtovic, Djordje ^e,bz   Machala, Ladislav ^f   Zangerle, Robert ^g   Mocroft, Amanda ^b,ct   Van Lunzen, Jan ^a   Losso, M ^h   Kundro, M ^h   Vetter, N ⁱ   Karpov, I ^j   Vassilenko, A ^j   Mitsura, V M ^k   Suetnov, O ^l   Clumeck, N ^m   De Wit, S ^m   Delforge, M ^m   Colebunders, R ⁿ   Vandekerckhove, L ^o   Hadziosmanovic, V ^p   Kostov, K ^q   Begovac, J ^r   Machala, L ^s   Jilich, D ^s   Sedlacek, D ^t   Nielsen, J ^u   Kronborg, G ^u   Benfield, T ^u   Larsen, M ^u   Gerstoft, J ^c   Katzenstein, T ^c   Hansen, A B E ^c   Skinhoj P ^c   Pedersen, C ^v   Ostergaard, L ^w   Zilmer, K ^x   Smidt, Jelena ^y   Ristola, M ^z   Katlama, C ^aa   Viard, J P ^ab   Girard, P M ^ac   Livrozet, J M ^ad   Vanhems, P ^ae   Pradier, C ^af   Dabis, F ^ag   Neau, D ^ag   Rockstroh, J ^ah   Schmidt, R ^ai   Degen, O ^a   Stellbrink, H J ^aj   Staszewski, S ^ak   Goethe, J W ^ak   Bogner, J ^al   Fatkenheuer G ^am   Kosmidis, J ^an   Gargalianos, P ^an   Xylomenos, G ^an   Perdios, J ^an   Panos, G ^ao   Filandras, A ^ao   Karabatsaki, E ^ao   Sambatakou, H ^ap   Banhegyi, D ^aq   Mulcahy, F ^ar   Yust, I ^as   Turner, D ^as   Burke, M ^as   Pollack, S ^at   Hassoun, G ^at   Maayan, S ^au   Vella, S ^av   Esposito, R ^aw   Mazeu, I ^aw   Mussini, C ^aw   Rici, C ^ax   Pristera, R ^ay   Mazzotta, F ^az   Gabbuti, A ^az   Vullo, V ^ba   Lichtner, M ^ba   Chirianni, A ^bb   Montesarchio, E ^bb   Gargiulo, M ^bb   Antonucci, G ^bc   Testa, A ^bc   D'Offizi, G ^bc   Vlassi, C ^bc   Zaccarelli, M ^bc   Antorini, A ^bc   Lazzarin, A ^bd   Castagna, A ^bd   Gianotti, N ^bd   Galli, M ^be   Ridolfo, A ^be   D'Arminio Monforte, A ^bf   Rozentale, B ^bg   Zeltina, I ^bg   Chaplinskas, S ^bh   Staub, T ^bi   Hemmer, R ^bi   Ormaasen, V ^bk   Maeland, A ^bk   Bruun, J ^bk   Knysz, B ^bl   Gasiorowski, J ^bl   Horban, A ^bm   Bakowska, E ^bm   Grzeszczuk, A ^bn   Flisiak, R ^bn   Boron Kaczmarska, A ^bo   Pynka, M ^bo   Parczewski, M ^bo   Beniowski, M ^bp   Mularska, E ^bp   Trocha, H ^bq   Jablonowska, E ^br   Malolepsza, E ^br   Wojcik, K ^br   Antunes, F ^bs   Doroana, M ^bs   Caldeira, L ^bs   Mansinho, K ^bt   Maltez, F ^bu   Duiculescu, D ^bv   Rakhmanova, A ^bw   Zakharova, N ^bx   Buzunova, S ^by   Mokras M ^ca   Stanekova D ^ca   Tomazic, J ^cb   Gonzalez Lahoz J ^cc   Soriano, V ^cc   Labarga, P ^cc   Medrano, J ^cc   Moreno, S ^cd   Rodriguez, J M ^cd   Clotet, B ^ce   Jou, A ^ce   Paredes, R ^ce   Tural, C ^ce   Puig, J ^ce   Bravo, I ^ce   Gatell Artigas, Josep María ^cf,cy   Miro J M ^cf   Domingo, P ^cg   Gutierrez, M ^cg   Mateo, G ^cg   Sambeat, M A ^cg   Blaxhult, A ^ch   Flamholc, L ^ci   Ledergerber, B ^cj   Weber, R ^cj   Francioli, P ^ck   Cavassini, M ^ck   Hirschel, B ^cl   Boffi, E ^cl   Furrer, H ^cm   Battegay, M ^cn   Elzi, L ^cn   Kravchenko, E ^co   Chentsova, N ^co   Frolov, V ^cp   Kutsyna, G ^cp   Servitskiy, S ^cq   Krasnov, M ^cr   Barton, S ^cs   Johnson, A M ^ct   Mercey, D ^ct   Phillips, A ^ct   Johnson, M A ^ct   Murphy, M ^cu   Weber, J ^cv   Scullard, G ^cv   Fisher, M ^cw   Leen, C ^cx   Gazzard, B ^cy   Grint, D ^cy   Podlekareva, D ^cy   Kjaer J ^cy,cy   Peters, L ^cy   Tverland, J ^cy   Raben, D ^cy   Fischer, A H ^cy   Schultze, A ^cy   Shepherd, L ^cy   Grarup, J ^cy   Thiebaut, R ^cy   Burger, D ^cy   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF BELGRADE   (Serbia)

^f CHARLES UNIVERSITY   (Czech Republic)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h HOSPITAL RAMOS MEJÍA   (Argentina)

ⁱ Pulmologisches Zentrum   (Austria)

^j BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^k GOMEL STATE MEDICAL UNIVERSITY   (Belarus)

^l Regional AIDS Centre   (Belarus)

^m SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

ⁿ INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^o GHENT UNIVERSITY HOSPITAL   (Belgium)

^p Klinicki Centar Univerziteta Sarajevo   (Bosnia and Herzegovina)

^q Infectious Diseases Hospital   (Bulgaria)

^r Croatia   (Croatia)

^s UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^t CHARLES UNIVERSITY   (Czech Republic)

^u HVIDOVRE HOSPITAL   (Denmark)

^v ODENSE UNIVERSITY HOSPITAL   (Denmark)

^w AARHUS UNIVERSITY HOSPITAL   (Denmark)

^x WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^y Nakkusosakond Siseklinik   (Estonia)

^z UNIVERSITY OF HELSINKI   (Finland)

^aa PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ab HÔPITAL NECKER ENFANTS MALADES   (France)

^ac HÔPITAL SAINT ANTOINE   (France)

^ad EDOUARD HERRIOT HOSPITAL   (France)

^ae UNIVERSITÉ LYON 1   (France)

^af CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^ag INSERM   (France)

^ah UNIVERSITY HOSPITAL BONN   (Germany)

^ai HANNOVER MEDICAL SCHOOL   (Germany)

^aj IPM Study Center   (Germany)

^ak UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^al LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^am UNIVERSITY OF COLOGNE   (Germany)

^an IASO GENERAL HOSPITAL   (Greece)

^ao 1st IKA Hospital   (Greece)

^ap Ippokration Genereal Hospital   (Greece)

^aq Szent Laszlo Hospital   (Hungary)

^ar ST JAMES S HOSPITAL   (Ireland)

^as TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^at RAMBAM MEDICAL CENTER   (Israel)

^au HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^av ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^aw UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^ax OSPEDALI RIUNITI   (Italy)

^ay OSPEDALE CA FONCELLO   (Italy)

^az SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^ba SAPIENZA UNIVERSITY OF ROME   (Italy)

^bb MONALDI HOSPITAL   (Italy)

^bc NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^bd SAN RAFFAELE HOSPITAL   (Italy)

^be UNIVERSITY OF MILAN   (Italy)

^bf Istituto di Clinica Malattie Infettive e Tropicale   (Italy)

^bg Infectology Centre of Latvia   (Latvia)

^bh Lithuanian AIDS Centre   (Lithuania)

^bi CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^bj ACADEMIC MEDICAL CENTER   (Netherlands)

^bk ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^bl WROCLAW MEDICAL UNIVERSITY   (Poland)

^bm SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

^bn MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^bo POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bp Osrodek Diagnostyki i Terapii AIDS   (Poland)

^bq MEDICAL UNIVERSITY OF GDANSK   (Poland)

^br M Madurowicza I Oddzia Chorob   (Poland)

^bs HOSPITAL DE SANTA MARIA   (Portugal)

^bt HOSPITAL EGAS MONIZ   (Portugal)

^bu HOSPITAL CURRY CABRAL   (Portugal)

^bv VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^bw Medical Academy Botkin Hospital   (Russian Federation)

^bx St Petersburg AIDS Centre   (Russian Federation)

^by Nizhny Novgorod Center for AIDS and Infectious Diseases Prevention and Control   (Russian Federation)

^bz Institute for Infectious and Tropical Diseases   (Serbia)

^ca Derer 's University Hospital Slovakia   (Slovakia)

^cb UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^cc HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^cd HOSPITAL RAMÓN Y CAJAL   (Spain)

^ce HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^cf HOSPITAL CLÍNIC   (Spain)

^cg HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^ch STOCKHOLM SÖDER HOSPITAL   (Sweden)

^ci LUND UNIVERSITY HOSPITAL   (Sweden)

^cj UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^ck LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^cl GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^cm UNIVERSITY OF BERN   (Switzerland)

^cn UNIVERSITY HOSPITAL BASEL   (Switzerland)

^co Kiev Centre for AIDS   (Ukraine)

^cp Lugansk State Medical University   (Ukraine)

^cq Odessa Region AIDS Center   (Ukraine)

^cr KHARKIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^cs CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^ct ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^cu ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^cv IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^cw ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^cx WESTERN GENERAL HOSPITAL   (United Kingdom)

^cy Western General Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANGIOPLASTY; ARTICLE; CAROTID ENDARTERECTOMY; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; END STAGE RENAL DISEASE; EUROPE; FEMALE; HEART INFARCTION; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOVIROLOGICAL DISCORDANCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PANCREATITIS; PROSPECTIVE STUDY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; EUROPE; FEMALE; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84900323491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087160     Document Type: Article

References (28)

1. Hughes MD, Daniels MJ, Fischl MA, Kim S, Schooley RT (1998) CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. AIDS 12: 1823-1832. (Pubitemid 28454448)
2. Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, et al. (1999) Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS 13: 951-956. (Pubitemid 29240190)
3. Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, et al. (2008) Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 9: 397-405. (Pubitemid 352015643)
4. Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, et al. (2007) Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 370: 407-413. (Pubitemid 47176633)
5. Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, et al. (2009) Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 48: 787-794.
6. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, et al. (2009) Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis 48: 350-361.
7. Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, et al. (1999) Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med 130: 570-577. (Pubitemid 29169384)
8. Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, et al. (2008) Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 47: 553-558. (Pubitemid 351442024)
9. Moore DM, Hogg RS, Yip B, Wood E, Tyndall M, et al. (2005) Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy. J Acquir Immune Defic Syndr 40: 288-293. (Pubitemid 41533068)
10. Zoufaly A, an der Heiden M, Kollan C, Bogner JR, Fatkenheuer G, et al. (2011) Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy. J Infect Dis 203: 364-371.
11. Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, et al. (2010) Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 55: 262-270.
12. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, et al. (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352: 1725-1730.
13. revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 17: 1-19.
14. Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, et al. (2011) A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study. HIV Clin Trials 12: 109-117.
15. Shrier I, Platt RW (2008) Reducing bias through directed acyclic graphs. BMC Med Res Methodol 8: 70.
16. Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, et al. (2002) Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol 31: 951-958. (Pubitemid 35446867)
17. Moore RD, Gebo KA, Lucas GM, Keruly JC (2008) Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. Clin Infect Dis 47: 1102-1104.
18. Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, et al. (2012) The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression. Antivir Ther.
19. Lapadula G, Cozzi-Lepri A, Marchetti G, Antinori A, Chiodera A, et al. (2013) Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment AIDS 27: 769-779.
20. Gazzola L, Tincati C, Bellistri GM, Monforte A, Marchetti G (2009) The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. Clin Infect Dis 48: 328-337.
21. Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, et al. (2009) Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J Infect Dis 199: 1648-1656.
22. HellebergM, Kronborg G, Larsen C, Pedersen G, Pedersen C, et al. (2013) Poor CD4 response despite viral suppression is associated with increased non-AIDS-related mortality among HIV patients and their parents. AIDS 27: 1021-1026.
23. Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, et al. (2012) Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+ T cells. J Infect Dis.
24. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, et al. (2009) Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23: 1059-1067.
25. Monforte A, Abrams D, Pradier C, Weber R, Reiss P, et al. (2008) HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 22: 2143-2153.
26. Kesselring A, Gras L, Smit C, van Twillert G, Verbon A, et al. (2011) Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV- 1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis 52: 1458-1465.
27. Abrams D, Levy Y, Losso MH, Babiker A, Collins G, et al. (2009) Interleukin-2 therapy in patients with HIV infection. N Engl J Med 361: 1548-1559.
28. Lanzafame M, Lattuada E, Vento S (2009) Maraviroc and CD4+ cell count recovery in patients with virologic suppression and blunted CD4+ cell response. AIDS 27: 869.